TheBlock
Hyperliquid Strategies Inc., the Nasdaq-listed HYPE token treasury firm trading under the PURR ticker, reported a $165.4 million net loss for the nine months ended March 31, even as it materially expanded the underlying token position. The loss is "primarily attributable" to $64 million in net unrealized losses on its HYPE holdings, a one-time $35.6 million write-off tied to the legacy Sonnet BioTherapeutics business, and a $60.5 million increase in deferred tax expense, according to the firm's fiscal Q3 filing on Thursday.
The company now holds roughly 20 million HYPE tokens, having deployed $216 million to acquire approximately 7.3 million HYPE since its December 2025 inception. It also spent $10.5 million to repurchase about 3 million PURR shares at an average cost of $3.42, and holds a $103 million cash position earmarked for further treasury deployments, buybacks, and corporate expenses.
Why it matters
The headline loss looks worse than the operating reality, and the split is the story. Roughly $124 million of the $165.4 million net loss comes from non-cash items — unrealized HYPE price moves, a one-time bio write-off tied to the reverse-merger shell, and a deferred-tax accrual. Staking revenue of $2.6 million for the quarter and $1 million in interest income do not yet cover $7.2 million in operating expenses, but the gap is small relative to the treasury's notional size and the cash buffer kept on the balance sheet.
CEO David Schamis framed the quarter as "meaningful progress in establishing HSI as the leading public vehicle for capital efficient HYPE exposure," pointing to the validator partnership with Unit and the disposition of legacy bio-tech operations as proof the firm is converging on a pure-play HYPE treasury model.
Market impact
PURR also launched options trading on its common stock on the Nasdaq Options Market in March, giving traders a new hedging instrument against the underlying HYPE treasury. For the HYPE market, the filing is a reminder that public-company exposure to a single token carries mechanical earnings volatility — every HYPE drawdown now flows through a Nasdaq income statement.
Frequently asked questions
-
Why did Hyperliquid Strategies report a $165M net loss?
The nine-month loss is mostly non-cash: $64M in net unrealized losses on its HYPE treasury, a $35.6M one-time write-off tied to the legacy Sonnet BioTherapeutics business, and a $60.5M increase in deferred tax expense.
-
How large is Hyperliquid Strategies' HYPE treasury?
The firm holds roughly 20 million HYPE tokens, having deployed $216 million to acquire approximately 7.3 million HYPE since its December 2025 inception. It also holds a $103 million cash position for further deployments and buybacks.
-
Is the $165M loss an operating cash problem?
No. About $124M of the loss is non-cash items. Q3 staking revenue of $2.6M and $1M in interest income did not yet cover $7.2M in operating expenses, but the gap is small relative to the treasury's notional size.
-
What is Hyperliquid Strategies' strategy?
It operates as a public vehicle for HYPE exposure, maximizing shareholder value through staking, yield optimization, and ecosystem participation. It also launched options trading on its common stock PURR on the Nasdaq Options Market in March.
-
What signals should investors watch next?
The $103M cash position will dictate the cadence of incremental HYPE accumulation. Staking revenue versus operating expenses, and the gap between market cap and underlying HYPE holdings, will also be key signals.
CoinDesk
Crypto Rank News
WuBlockchain